EE+ POEM Archive
Rimonabant: weight loss at risk of serious adverse events
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Rimonabant: Weight Loss at Risk of Serious Adverse Events." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events.
Rimonabant: weight loss at risk of serious adverse events. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events. Accessed October 1, 2023.
Rimonabant: weight loss at risk of serious adverse events. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events
Rimonabant: Weight Loss at Risk of Serious Adverse Events [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rimonabant: weight loss at risk of serious adverse events
ID - 426116
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
